181 related articles for article (PubMed ID: 19775470)
1. Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: a cross-sectional study.
Pathai S; Deshpande A; Gilbert C; Lawn SD
BMC Infect Dis; 2009 Sep; 9():158. PubMed ID: 19775470
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
Shah SU; Kerkar SP; Pazare AR
Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644
[TBL] [Abstract][Full Text] [Related]
3. Ocular manifestations in patients attending antiretroviral therapy centre at a tertiary care hospital in Himachal Pradesh, India.
Sharma M; Chauhan A; Sharma G; Chauhan V
Indian J Med Res; 2018 May; 147(5):496-500. PubMed ID: 30082574
[TBL] [Abstract][Full Text] [Related]
4. Ocular diseases among HIV/AIDS patients in Jakarta, Indonesia.
Lestari YD; Sitompul R; Edwar L; Djoerban Z
Southeast Asian J Trop Med Public Health; 2013 Jan; 44(1):62-71. PubMed ID: 23682439
[TBL] [Abstract][Full Text] [Related]
5. Ocular manifestation of HIV/AIDS and correlation with CD4+ cells count among adult HIV/AIDS patients in Jimma town, Ethiopia: a cross sectional study.
Bekele S; Gelaw Y; Tessema F
BMC Ophthalmol; 2013 May; 13():20. PubMed ID: 23710936
[TBL] [Abstract][Full Text] [Related]
6. Differing spectrum of HIV-associated ophthalmic disease among patients starting antiretroviral therapy in India and South Africa.
Pathai S; Gilbert C; Weiss HA; McNally M; Lawn SD
Trop Med Int Health; 2011 Mar; 16(3):356-9. PubMed ID: 21371217
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China.
Luo J; Jing D; Kozak I; Huiming Z; Siying C; Yezhen Y; Xin Q; Luosheng T; Adelman RA; Forster SH
Ophthalmic Epidemiol; 2013 Jun; 20(3):170-5. PubMed ID: 23713918
[TBL] [Abstract][Full Text] [Related]
8. Ocular complications in HIV positive patients on antiretroviral therapy in Ghana.
Martin-Odoom A; Bonney EY; Opoku DK
BMC Ophthalmol; 2016 Aug; 16():134. PubMed ID: 27487853
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ocular manifestations and blindness in HIV/AIDS patients in a tertiary care hospital in South India.
Ganekal S; Jhanji V; Dorairaj S; Nagarajappa A
Ocul Immunol Inflamm; 2012 Oct; 20(5):336-41. PubMed ID: 22775065
[TBL] [Abstract][Full Text] [Related]
10. Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /μL.
Nishijima T; Yashiro S; Teruya K; Kikuchi Y; Katai N; Oka S; Gatanaga H
PLoS One; 2015; 10(9):e0136747. PubMed ID: 26375282
[TBL] [Abstract][Full Text] [Related]
11. Ocular inflammatory disease and ocular tuberculosis in a cohort of patients co-infected with HIV and multidrug-resistant tuberculosis in Mumbai, India: a cross-sectional study.
Mehta S; Mansoor H; Khan S; Saranchuk P; Isaakidis P
BMC Infect Dis; 2013 May; 13():225. PubMed ID: 23687908
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
[TBL] [Abstract][Full Text] [Related]
13. Study of prevalence of ocular manifestations in HIV positive patients.
Saini N; Hasija S; Kaur P; Kaur M; Pathania V; Singh A
Nepal J Ophthalmol; 2019 Jan; 11(21):11-18. PubMed ID: 31523061
[TBL] [Abstract][Full Text] [Related]
14. Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A cross-sectional study.
Gunda DW; Godfrey KG; Kilonzo SB; Mpondo BC
Malawi Med J; 2017 Mar; 29(1):43-52. PubMed ID: 28567196
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of lower limb deep venous thrombosis among adult HIV positive patients attending an outpatient clinic at Mulago Hospital.
Vululi ST; Bugeza S; Zeridah M; Ddungu H; Openy AB; Frank M; Parkes-Ratanshi R
AIDS Res Ther; 2018 Jan; 15(1):3. PubMed ID: 29370816
[TBL] [Abstract][Full Text] [Related]
16. Hearing impairment and deafness among HIV infected children and adolescents in Harare, Zimbabwe.
Chidziva C; Matsekete J; Bandason T; Shamu S; Dzongodza T; Matinhira N; Mujuru HA; Kunzekwenyika C; Wellington M; Luthy R; Prescott C; Ferrand RA
Cent Afr J Med; 2015; 61(9-12):56-61. PubMed ID: 29144062
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
[TBL] [Abstract][Full Text] [Related]
18. Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.
Sun J; Liu L; Shen J; Chen P; Lu H
BMC Infect Dis; 2017 Apr; 17(1):285. PubMed ID: 28420350
[TBL] [Abstract][Full Text] [Related]
19. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
Siegfried N; Uthman OA; Rutherford GW
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
[TBL] [Abstract][Full Text] [Related]
20. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
[No Abstract] [Full Text] [Related]
[Next] [New Search]
